| scholarly article | Q13442814 |
| P356 | DOI | 10.1182/BLOOD-2013-12-546309 |
| P8608 | Fatcat ID | release_ag7rh6ryuffkjemsfakifkrocm |
| P932 | PMC publication ID | 4199956 |
| P698 | PubMed publication ID | 25171927 |
| P5875 | ResearchGate publication ID | 267755837 |
| P50 | author | Manuel R. Teixeira | Q41584388 |
| Noel De Miranda | Q42825686 | ||
| Apostolos Zaravinos | Q56419727 | ||
| Susana Lisboa | Q58285812 | ||
| Qiang Pan-Hammarström | Q67470492 | ||
| Gunilla Enblad | Q89897301 | ||
| P2093 | author name string | Yixin Zeng | |
| Longyun Chen | |||
| Zhibo Gao | |||
| Chenglin Wu | |||
| Roujun Peng | |||
| Konstantinos Georgiou | |||
| P2860 | cites work | Human deltex is a conserved regulator of Notch signalling | Q24317290 |
| Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles | Q24536351 | ||
| Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing | Q24612248 | ||
| Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma | Q24613755 | ||
| Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma | Q24630610 | ||
| Fast and accurate short read alignment with Burrows-Wheeler transform | Q24653853 | ||
| Jalview Version 2--a multiple sequence alignment editor and analysis workbench | Q24655519 | ||
| Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma | Q24676965 | ||
| Epstein-Barr virus immortalization: Notch2 interacts with CBF1 and blocks differentiation | Q24678677 | ||
| The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma | Q27824784 | ||
| Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin | Q27851546 | ||
| Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling | Q27860529 | ||
| Gain- and loss-of-function Lyn mutant mice define a critical inhibitory role for Lyn in the myeloid lineage | Q28201770 | ||
| Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray | Q28204313 | ||
| Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas | Q28207345 | ||
| Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration | Q28264933 | ||
| Defective negative regulation of antigen receptor signaling in Lyn-deficient B lymphocytes | Q28271869 | ||
| Global epidemiology of hepatitis B virus | Q28298592 | ||
| Oncogenically active MYD88 mutations in human lymphoma | Q28301648 | ||
| Discovery and saturation analysis of cancer genes across 21 tumour types | Q28305204 | ||
| Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation | Q28584704 | ||
| Inactivating mutations of acetyltransferase genes in B-cell lymphoma | Q29031276 | ||
| Diverse somatic mutation patterns and pathway alterations in human cancers | Q29619825 | ||
| Diffuse large B-cell lymphoma--more than a diffuse collection of large B cells: an entity in search of a meaningful classification | Q33488667 | ||
| Germline Variation Controls the Architecture of Somatic Alterations in Tumors | Q33707388 | ||
| Developmental acquisition of the Lyn-CD22-SHP-1 inhibitory pathway promotes B cell tolerance | Q33732451 | ||
| Aberrant expression and reverse signalling of CD70 on malignant B cells | Q33872027 | ||
| SNP detection for massively parallel whole-genome resequencing | Q34017409 | ||
| VarScan: variant detection in massively parallel sequencing of individual and pooled samples | Q34018143 | ||
| Deltex1 redirects lymphoid progenitors to the B cell lineage by antagonizing Notch1. | Q34116313 | ||
| Analysis of the coding genome of diffuse large B-cell lymphoma | Q34205133 | ||
| Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma. | Q34277639 | ||
| Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction | Q34307627 | ||
| Agonist anti-human CD27 monoclonal antibody induces T cell activation and tumor immunity in human CD27-transgenic mice | Q34370354 | ||
| Mechanisms of chromosomal translocations in B cell lymphomas | Q34405423 | ||
| Deltex-1 activates mitotic signaling and proliferation and increases the clonogenic and invasive potential of U373 and LN18 glioblastoma cells and correlates with patient survival | Q34603835 | ||
| The double-edged sword of Notch signaling in cancer | Q35989577 | ||
| The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development | Q36193517 | ||
| Genetic heterogeneity of diffuse large B-cell lymphoma | Q36567845 | ||
| Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma | Q36629205 | ||
| Recurrent targets of aberrant somatic hypermutation in lymphoma | Q37030889 | ||
| Germinal centres: role in B-cell physiology and malignancy | Q37039584 | ||
| High-resolution mapping of copy-number alterations with massively parallel sequencing | Q37072451 | ||
| Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing | Q37098851 | ||
| DNA repair genes are selectively mutated in diffuse large B cell lymphomas | Q37125781 | ||
| Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome | Q37246532 | ||
| Multiple roles of Lyn kinase in myeloid cell signaling and function | Q37416257 | ||
| Correlating notch signaling with thymocyte maturation | Q37462948 | ||
| Timing and tuning of CD27-CD70 interactions: the impact of signal strength in setting the balance between adaptive responses and immunopathology | Q37474941 | ||
| Targeting pathological B cell receptor signalling in lymphoid malignancies | Q38085501 | ||
| Regulation of innate and adaptive immunity by Notch | Q38105858 | ||
| Recurrent deletions of the TNFSF7 and TNFSF9 genes in 19p13.3 in diffuse large B-cell and Burkitt lymphomas | Q39418718 | ||
| Combined genetic inactivation of β2-Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma | Q39433857 | ||
| Oncogenic CARD11 mutations in human diffuse large B cell lymphoma | Q40005246 | ||
| The GCB subtype of diffuse large B-cell lymphoma is less frequent in Asian countries | Q40221294 | ||
| Differences in the cytogenetic alteration profiles of diffuse large B-cell lymphoma among Chinese and American patients | Q45391275 | ||
| AID is required for germinal center-derived lymphomagenesis | Q46861217 | ||
| The costimulatory molecule CD70 is regulated by distinct molecular mechanisms and is associated with overall survival in diffuse large B-cell lymphoma. | Q50953796 | ||
| Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population. | Q51007392 | ||
| National survey of drug-resistant tuberculosis in China | Q64125840 | ||
| P433 | issue | 16 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2544-2553 | |
| P577 | publication date | 2014-08-29 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Exome sequencing reveals novel mutation targets in diffuse large B-cell lymphomas derived from Chinese patients | |
| P478 | volume | 124 |
| Q48158448 | A broad atlas of somatic hypermutation allows prediction of activation-induced deaminase targets. |
| Q35129157 | Aberrant recombination and repair during immunoglobulin class switching in BRCA1-deficient human B cells |
| Q38959472 | Advances in the molecular diagnosis of diffuse large B-cell lymphoma in the era of precision medicine |
| Q58742871 | B cells with aberrant activation of Notch1 signaling promote Treg and Th2 cell-dominant T-cell responses via IL-33 |
| Q33809728 | B-cell Function Gene Mutations in Diffuse Large B-cell Lymphoma: A Retrospective Cohort Study |
| Q102142158 | Clinical Significance of Down-Regulated CD70 and CD27 Expression in Poor Prognosis of Esophageal Squamous Cell Carcinoma |
| Q88084601 | Clinical and functional impact of recurrent S1PR1 mutations in mantle cell lymphoma |
| Q27027493 | Clinical impact of recurrently mutated genes on lymphoma diagnostics: state-of-the-art and beyond |
| Q37549738 | Combined immunodeficiency and Epstein-Barr virus-induced B cell malignancy in humans with inherited CD70 deficiency |
| Q26776038 | Cracking the Code of Human Diseases Using Next-Generation Sequencing: Applications, Challenges, and Perspectives |
| Q92022489 | De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways |
| Q42336333 | Deltex-1 mutations predict poor survival in diffuse large B-cell lymphoma |
| Q38372504 | Flow cytometric sorting coupled with exon capture sequencing identifies somatic mutations in archival lymphoma tissues |
| Q98281008 | Genetic heterogeneity and prognostic impact of recurrent ANK2 and TP53 mutations in mantle cell lymphoma: a multi-centre cohort study |
| Q38739035 | Genetic heterogeneity in primary and relapsed mantle cell lymphomas: Impact of recurrent CARD11 mutations. |
| Q38669131 | Genetic landscape and deregulated pathways in B-cell lymphoid malignancies |
| Q52653323 | Genetic landscape of hepatitis B virus-associated diffuse large B-cell lymphoma. |
| Q95940670 | Genome-defined African ancestry is associated with distinct mutations and worse survival in patients with diffuse large B-Cell lymphoma |
| Q57059909 | Genome-wide discovery of somatic regulatory variants in diffuse large B-cell lymphoma |
| Q91737485 | Genomic Alterations In Primary Cardiac Diffuse Large B Cell Lymphoma: A Case Report And Literature Review |
| Q88654101 | Genomic landscape and prognostic analysis of mantle cell lymphoma |
| Q38364884 | Germinal centres and B cell lymphomagenesis |
| Q38756189 | Germline mutations predisposing to diffuse large B-cell lymphoma. |
| Q60921239 | Identification of recurrent noncoding mutations in B-cell lymphoma using capture Hi-C |
| Q37549726 | Inherited CD70 deficiency in humans reveals a critical role for the CD70-CD27 pathway in immunity to Epstein-Barr virus infection |
| Q51259501 | Molecular Pathogenesis of Diffuse Large B-Cell Lymphoma. |
| Q92052628 | Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling |
| Q57909099 | Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes |
| Q59791012 | Mutational Evolution in Relapsed Diffuse Large B-Cell Lymphoma |
| Q94571342 | Mutational dynamics and immune evasion in diffuse large B-cell lymphoma explored in a relapse-enriched patient series |
| Q27304386 | Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review |
| Q35672428 | Revealing Genomic Profile That Underlies Tropism of Myeloma Cells Using Whole Exome Sequencing |
| Q42377155 | Signatures of positive selection reveal a universal role of chromatin modifiers as cancer driver genes |
| Q47709959 | Single-agent ibrutinib in relapsed or refractory follicular lymphoma: a phase 2 consortium trial. |
| Q58088024 | TIRAP p.R81C is a novel lymphoma risk variant which enhances cell proliferation via NF-κB mediated signaling in B-cells |
| Q57475962 | Targeted next generation sequencing reveals high mutation frequency of , and in high-grade B-cell lymphoma with and and /or rearrangements |
| Q90428426 | Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report |
| Q64092509 | Transmission of diffuse large B-cell lymphoma by an allogeneic stem-cell transplant |
| Q62490013 | Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma |
| Q61053563 | Whole exome sequencing of relapsed/refractory patients expands the repertoire of somatic mutations in diffuse large B-cell lymphoma |
| Q33701845 | Whole-exome analysis reveals novel somatic genomic alterations associated with cell of origin in diffuse large B-cell lymphoma |
| Q36392470 | Whole-genome sequencing reveals activation-induced cytidine deaminase signatures during indolent chronic lymphocytic leukaemia evolution |
Search more.